Cyclin L1 participates in Adriamycin resistance and progression of osteosarcoma via PI3K/AKT-mTOR pathway

Yanbin Zhang(Capital Medical University), Xiaobing Jiang(Union Hospital)
Aging
June 26, 2024
Cited by 0


Related Papers